Zaina Hamza, MedPage Today

Zaina Hamza

MedPage Today

Contact Zaina

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • MedPage Today

Past articles by Zaina:

FDA OKs Risankizumab for Crohn's Disease

Approval marks the third indication for the IL-23 inhibitor in adults → Read More

Biologics for Crohn's Go Head to Head

Ustekinumab, adalimumab both effective in SEAVUE trial, with no difference in remissions → Read More

Antibiotics Heighten Risk for IBD in Seniors

Registry-based study finds association with antibiotics that target gastrointestinal pathogens → Read More

Empirical Evidence Points to Benefit of Earlier Colon Cancer Screening

Findings from Nurses' Health Study II lend support to latest recommendations → Read More

First Drug Approved for Wilson's Disease in Decades

Oral trientine tetrahydrochloride gains indication for adults who are tolerant to penicillamine → Read More

Study Debunks COVID Vaccine Side Effect?

Danish study finds no association between mRNA vaccines and appendicitis → Read More

CDC Issues Advisory on Mystery Hepatitis Cases in Kids

Agency eyes adenovirus infection as possible cause behind recently reported cases → Read More

Appendicitis: Which Factors Predict Who Goes Under the Knife?

Clinical risk factors were not as important, study finds → Read More

Did HIV Status Affect Transplant Patients' Long-Term Outcomes?

Study argues liver, kidney transplantation is a viable option for patients with HIV → Read More

How High Is Breakthrough Infection Risk for People With Arthritis, HIV?

Real-world dataset supports need for extra doses in immunocompromised groups → Read More

Year in Review: Crohn's Disease

First interchangeable biosimilar approved, biologics go head-to-head → Read More

Can Lighter-Weight Mesh Cut Pain in Open Ventral Hernia Repair?

Head-to-head trial pits medium-weight polypropylene meshes against heavy-weight mesh → Read More

More Evidence Supports CRC Screening at Younger Ages

Historical data among adults ages 45 to 50 show ominous trends → Read More

Certain Groups Left Behind in HIV Preventive Care

Gaps in PrEP use more likely among minority groups, young people, and those with SUD → Read More

Study: Exposure Therapy for Irritable Bowel Syndrome Saves Money

Adding exposure to internet-based cognitive behavioral therapy could cut costs in the long run → Read More